PerkinElmer inks new distribution deal with Roche
PerkinElmer Inc. (NYSE: PKI) has entered into a new supply agreement with Switzerland’s Roche for distribution of the NimbleGen CGX microarray workflow the two developed together.
Starting in January of 2012, Waltham-based PerkinElmer will assume responsibility from Roche for sales, service and support of the CGX array workflow for most countries outside of the U.S., according to a release. Roche will still sell the cytogenetic testing system in the U.S. and other select markets. The two companies started working together on a cytogenetics array workflow in 2009.